Clinical Trial Update: An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease Chamber [Phase 2]

View source ↗

Summary

Phase 2 exploratory crossover trial comparing Reproxalap with Lifitegrast for dry eye disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Lifitegrast (lifitegrast)
• Reproxalap (reproxalap)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2025-02-28